Schwyz-based Liom, an innovator in non-invasive biomarker monitoring and the developer of a non-invasive glucose-monitoring wearable, announced a €13.9
Schwyz-based Liom, an innovator in non-invasive biomarker monitoring and the developer of a non-invasive glucose-monitoring wearable, announced a €13.9 million (CHF 13 million) extension of its Series A financing round.
The round was led by previous … [3899 chars]
Source: EUROPE SAYS | Published: 2025-12-19T11:44:18Z
Credit: EUROPE SAYS
